Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS)
PLOS ONE · 10.08.2023 · 18 (8) · e0286358
DOI: 10.1371/journal.pone.0286358 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 10.08.2023. Verfasst von Zhengwei Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China. Hauptthemen laut MEDLINE: Brucella, Vaccines, Brucellosis. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund, Xinjiang Uygur Autonomous Region science and technology support project.
Abstract (Originalsprache)
Brucellosis is a common zoonosis, which is caused by Brucella infection, and Brucella often infects livestock, leading to abortion and infertility. At present, human brucellosis remains one of the major public health problems in China. According to previous research, most areas in northwest China, including Xinjiang, Tibet, and other regions, are severely affected by Brucella. Although there are vaccines against animal Brucellosis, the effect is often poor. In addition, there is no corresponding vaccine for human Brucellosis infection. Therefore, a new strategy for early prevention and treatment of Brucella is needed. A multi-epitope vaccine should be developed. In this study, we identified the antigenic epitopes of the Brucella type IV secretion system VirB8 and Virb10 using an immunoinformatics approach, and screened out 2 cytotoxic T lymphocyte (CTL) epitopes, 9 helper T lymphocyte (HTL) epitopes, 6 linear B cell epitopes, and 6 conformational B cell epitopes. These advantageous epitopes are spliced together through different linkers to construct a multi-epitope vaccine. The silico tests showed that the multi-epitope vaccine was non-allergenic and had a strong interaction with TLR4 molecular docking. In immune simulation results, the vaccine construct may be useful in helping brucellosis patients to initiate cellular and humoral immunity. Overall, our findings indicated that the multi-epitope vaccine construct has a high-quality structure and suitable characteristics, which may provide a theoretical basis for the development of a Brucella vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
- Department of Immunology, School of Basic Medical Sciences, Xinjiang Medical University, Xinjiang, China.
- State Key Laboratory of Pathogenesis, Prevention, Treatment of Central Asian High Incidence Diseases, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China.
ORCID-Profile: Jianbing Ding, Fengbo Zhang
Förderung
- National Natural Science Foundation of China
- State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund
- Xinjiang Uygur Autonomous Region science and technology support project
- Youth Science and technology top talent Program
Zitieren
APA
Yin, Z., Li, M., Niu, C., Yu, M., Xie, X., Haimiti, G., Guo, W., Shi, J., He, Y., Ding, J., & Zhang, F. (2023). Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS). PLOS ONE, 18(8), e0286358. https://doi.org/10.1371/journal.pone.0286358
Vancouver
Yin Z, Li M, Niu C, Yu M, Xie X, Haimiti G, et al. Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS). PLOS ONE. 2023;18(8):e0286358. doi:10.1371/journal.pone.0286358
BibTeX
@article{Yin2023,
author = {Yin, Zhengwei and Li, Min and Niu, Ce and Yu, Mingkai and Xie, Xinru and Haimiti, Gulishati and Guo, Wenhong and Shi, Juan and He, Yueyue and Ding, Jianbing and Zhang, Fengbo},
title = {Design of multi-epitope vaccine candidate against Brucella type IV secretion system (T4SS)},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {8},
pages = {e0286358},
doi = {10.1371/journal.pone.0286358}
}
EUVIMED